OPTN - Optinose falls as FDA delays label expansion for Xhance product
2023-12-06 08:22:11 ET
More on OptiNose
- OptiNose, Inc. 2023 Q3 - Results - Earnings Call Presentation
- OptiNose, Inc. (OPTN) Q3 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on OptiNose
- Historical earnings data for OptiNose
- Financial information for OptiNose
For further details see:
Optinose falls as FDA delays label expansion for Xhance product